Vikas Dharnidharka
Overview
Explore the profile of Vikas Dharnidharka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashoor I, Al-Akash S, Kizilbash S, Moudgil A, Puliyanda D, Ranabothu S, et al.
Pediatr Transplant
. 2024 Apr;
28(3):e14743.
PMID: 38566336
Background: There are scant data on the effect of rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder (PTLD) in pediatric kidney transplant recipients with EBV DNAemia. Methods:...
2.
Twichell S, Ashoor I, Boynton S, Dharnidharka V, Kizilbash S, Erez D, et al.
Pediatr Nephrol
. 2023 Dec;
39(5):1459-1468.
PMID: 38082091
Background: Coronavirus disease of 2019 (COVID-19) has disproportionately affected adults with kidney disease. Data regarding outcomes among children with kidney disease are limited. The North American Pediatric Renal Trials Collaborative...
3.
The Preserving Kidney Function in Children With CKD (PRESERVE) Study: Rationale, Design, and Methods
Denburg M, Razzaghi H, Davies A, Dharnidharka V, Dixon B, Flynn J, et al.
Kidney Med
. 2023 Nov;
5(11):100722.
PMID: 37965485
Rationale & Objective: PRESERVE seeks to provide new knowledge to inform shared decision-making regarding blood pressure (BP) management for pediatric chronic kidney disease (CKD). PRESERVE will compare the effectiveness of...
4.
Axelrod D, Chang S, Lentine K, Schnitzler M, Norman D, Olyaei A, et al.
Transplantation
. 2021 Jul;
106(6):1227-1232.
PMID: 34310099
Background: The development of cytomegalovirus (CMV) infection after kidney transplant remains a significant cause of posttransplant morbidity, graft loss, and mortality. Despite appropriate antiviral therapy, recipients without previous CMV exposure...
5.
Chaudhuri A, Ozawa M, Everly M, Ettenger R, Dharnidharka V, Benfield M, et al.
J Am Soc Nephrol
. 2013 Mar;
24(4):655-64.
PMID: 23449533
The development of anti-donor humoral responses after transplantation associates with higher risks for acute rejection and 1-year graft survival in adults, but the influence of humoral immunity on transplant outcomes...
6.
Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients
Hurst F, Jindal R, Fletcher J, Dharnidharka V, Gorman G, Lechner B, et al.
Urology
. 2011 Apr;
77(6):1271-6.
PMID: 21459420
We carried out an analysis of the United States Renal Data System to determine the incidence, risk factors and prognosis of renal cell carcinoma (RCC) in a national population of...
7.
Dharnidharka V, Gupta S
Pediatr Transplant
. 2009 Mar;
13(5):521-3.
PMID: 19254268
No abstract available.
8.
Schwartz G, Kwong T, Erway B, Warady B, Sokoll L, Hellerstein S, et al.
Pediatr Nephrol
. 2008 Sep;
24(1):113-9.
PMID: 18769945
The purpose of this study was to validate serum creatinine (SCr) concentrations assayed in the Central Biochemistry Laboratory of the National Institutes of Health (NIH)-funded Chronic Kidney Disease in Children...
9.
Abbott K, Kimmel P, Dharnidharka V, Oglesby R, Agodoa L, Caillard S
Transplantation
. 2005 Dec;
80(10):1383-91.
PMID: 16340779
Background: Although cyclosporine use has been associated with an increased risk of new-onset gout after renal transplantation, the incidence and risk factors for new-onset gout have not been reported in...
10.
Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K
Transplantation
. 2005 Nov;
80(9):1233-43.
PMID: 16314791
Background: Posttransplant lymphoproliferative disorders (PTLD) still represent a major preoccupation after renal transplantation, even in the most recent years. Methods: We analyzed the incidence, risk, and prognostic factors of PTLD...